Association between RCAS1 expression and microenvironmental immune cell death in uterine cervical cancer

被引:43
作者
Sonoda, K
Miyamoto, S
Hirakawa, T
Yagi, H
Yotsumoto, F
Nakashima, M
Watanabe, T
Nakano, H
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, Fukuoka 8128582, Japan
[2] Fukuoka Univ, Fac Pharmaceut Sci, Dept Clin Pharmacol, Fukuoka 8140180, Japan
[3] RIKEN, Res Ctr Allergy & Immunol, Unit Immune Surveillance Res, Yokohama, Kanagawa 2300045, Japan
关键词
RCAS1; uterine cervical cancer; lymphocyte apoptosis;
D O I
10.1016/j.ygyno.2005.02.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The presence of regional lymph node metastasis is one of the prognostic factors for uterine cervical cancer. The development of metastasis requires that cancer cells avoid lymphocyte attack. Impaired lymphocyte function is mediated by apoptotic factors including receptor-binding cancer antigen expressed on SiSo cells (RCAS I), Fas ligand (FasL), and tumor necrosis factor-alpha (TNF-alpha). Our aim was to evaluate the association between expression of these factors and microenvironmental lymphocyte apoptosis in this disease. Methods. Imummohistochemical methods were used to determine the relationship between the expression of RCAS1, FasL, and TNF-alpha, and the number of apoptotic lymphocytes in primary lesions and metastatic lymph nodes in patients with cervical cancer. Results. Expression of these apoptosis-inducing molecules was quite different in primary tumors and metastatic lymph nodes: RCASI expression in lymph nodes was significantly higher than that in primary lesions (P < 0.0001), whereas FasL and TNF-alpha expressions at these two locations were not significantly different. The number of cells with positive expression of RCASI, but not of FasL or TNF-alpha, was significantly correlated with the number of apoptotic lymphocytes in uterine cervix and metastatic lymph nodes (P < 0.0001 for both). Conclusion. RCASI expression may be related to tumor cell evasion of immune surveillance via induction of lymphocyte apoptosis in primary lesions and metastatic lymph nodes in uterine cervical cancer. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:772 / 779
页数:8
相关论文
共 53 条
[1]   PROGNOSTIC FACTORS AND OPERATIVE TREATMENT OF STAGE-IB TO STAGE-IIB CERVICAL-CANCER [J].
BURGHARDT, E ;
PICKEL, H ;
HAAS, J ;
LAHOUSEN, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (04) :988-996
[2]   Medical progress - Cancer of the uterine cervix [J].
Cannistra, SA ;
Niloff, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) :1030-1038
[3]   TUMOR-NECROSIS-FACTOR - CHARACTERIZATION AT THE MOLECULAR, CELLULAR AND INVIVO LEVEL [J].
FIERS, W .
FEBS LETTERS, 1991, 285 (02) :199-212
[4]  
Foster R S Jr, 1996, Surg Oncol Clin N Am, V5, P79
[5]   The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma [J].
Fukuda K. ;
Tsujitani S. ;
Maeta Y. ;
Yamaguchi K. ;
Ikeguchi M. ;
Kaibara N. .
Gastric Cancer, 2002, 5 (4) :220-227
[6]   IDENTIFICATION OF PROGRAMMED CELL-DEATH INSITU VIA SPECIFIC LABELING OF NUCLEAR-DNA FRAGMENTATION [J].
GAVRIELI, Y ;
SHERMAN, Y ;
BENSASSON, SA .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :493-501
[7]   FROM DUKES THROUGH JASS - PATHOLOGICAL PROGNOSTIC INDICATORS IN RECTAL-CANCER [J].
HARRISON, JC ;
DEAN, PJ ;
ELZEKY, F ;
VANDERZWAGG, R .
HUMAN PATHOLOGY, 1994, 25 (05) :498-505
[8]   Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer [J].
Hashimoto, I ;
Kodama, J ;
Seki, N ;
Hongo, A ;
Yoshinouchi, M ;
Okuda, H ;
Kudo, T .
BRITISH JOURNAL OF CANCER, 2001, 85 (01) :93-97
[9]   High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker [J].
Hiraoka, K ;
Hida, Y ;
Miyamoto, M ;
Oshikiri, T ;
Suzuoki, M ;
Nakakubo, Y ;
Shinohara, T ;
Itoh, T ;
Shichinohe, T ;
Kondo, S ;
Kasahara, N ;
Katoh, H .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (03) :418-423
[10]   THE USE OF ANTIAVIDIN ANTIBODY AND AVIDIN - BIOTIN - PEROXIDASE COMPLEX IN IMMUNOPEROXIDASE TECHNIQUES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1981, 75 (06) :816-821